Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2026-02-25 @ 9:39 PM
Study NCT ID:
NCT01670032
Status:
COMPLETED
Last Update Posted:
2014-08-12
First Post:
2012-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
Sponsor:
NovaBay Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RD.06. SPR. 18216
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None